Incidence, risk factors and outcome of COVID19 patients affected by pneumothorax or pneumomediastinum: what do we know so far.
A. Farronato (Florence, Italy), C. Travaglia (Florence, Italy), A. Ravasin (Florence, Italy), V. Aprile (Pisa, Italy), E. Sicolo (Pisa, Italy), S. Romagnoli (Florence, Italy), A. Peris (Florence, Italy), R. Corzani (Siena, Italy), P. Paladini (Siena, Italy), M. Lucchi (Pisa, Italy), L. Voltolini (Florence, Italy), A. Gonfiotti (Florence, Italy)
Source: International Congress 2022 – Thoracic surgery: different perspectives of the field
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Farronato (Florence, Italy), C. Travaglia (Florence, Italy), A. Ravasin (Florence, Italy), V. Aprile (Pisa, Italy), E. Sicolo (Pisa, Italy), S. Romagnoli (Florence, Italy), A. Peris (Florence, Italy), R. Corzani (Siena, Italy), P. Paladini (Siena, Italy), M. Lucchi (Pisa, Italy), L. Voltolini (Florence, Italy), A. Gonfiotti (Florence, Italy). Incidence, risk factors and outcome of COVID19 patients affected by pneumothorax or pneumomediastinum: what do we know so far.. 299
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|